Multiple Erythema Lesions Obscured As Fungal Skin Infection

Allma KoÃ§inaj; Antigona GÃ«rÃ§ari; Mybera Ferizi; Edlira Lashi; Lorela Gjunkshi; Monika Fida

doi:10.3889/oamjms.2014.083

Authors

Allma KoÃ§inaj Clinic of Dermatology- UCCK, Dermatology, Tirana
Antigona GÃ«rÃ§ari Clinic of Dermatology- UCCK, Dermatology, Tirana
Mybera Ferizi Clinic of Dermatology- UCCK, Dermatology, Tirana
Edlira Lashi Outpatient Clinic, Family Physician, Tirana
Lorela Gjunkshi University of Florida, Dermatology, Gainesville, Florida
Monika Fida University Hospital Center of Tirana, Dermatology, Tirana

DOI:

https://doi.org/10.3889/oamjms.2014.083

Abstract

Erythema migrans is a ring like erythema, with a few centimeters in diameter. Usually it occur solitary, days to weeks after an infected tick bite. According to skin changes it can be manifested acutely such as erythema migrans in Lyme Borreliosis, borrelial lymphocytoma (subacute), or as a late Lyme disease with acrodermatitis chronica atrophicans. All stages of this disease can be treatable with antimicrobial agents. As a first case in our department with multiple lesions, we describe a 14-year-old female and review the patientâ€™s clinical and laboratory features, the causes of the disease, diagnosis as well as treatment.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

LipschÃ¼tz B. Zur Kenntnis der "Erythema chronicum migrans. Acta dermato-venereologica. 1931;12: 100â€“2.

Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008; 83(5):566-71. DOI: https://doi.org/10.4065/83.5.566

Diza E, Papa A, Vezyri E, Tsounis S, Milonas I, Antioniadis A. Borrelia valaisiana in cerebrospinal fluid. Emerg Infect Dis. 2004; 10(9):1692-3. DOI: https://doi.org/10.3201/eid1009.030439

Constantin C, Peter O, Cerottini J, Derighetti M, Panizzon R, Guggisberg D. Erythema migrans with multiple lesions. Ann Dermatol Venereol. 2000;127(5):513-6.

MÃ¼llegger RR, Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol. 2008;9(6):355-68. DOI: https://doi.org/10.2165/0128071-200809060-00002

Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22(2): 235â€“60. DOI: https://doi.org/10.1016/j.idc.2007.12.012

Auwaerter PG, Aucott J, Dumler JS. Lyme borreliosis (Lyme disease): molecular and cellular pathobiology and prospects for prevention, diagnosis and treatment. Expert Rev Mol Med. 2004;6(2):1-22. DOI: https://doi.org/10.1017/S1462399404007276

Wormser GP, Nowakowski J, Nadelman RB, Visintainer P, Levin A, Aguero-Rosenfeld ME. Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease Clin Vaccine Immunol. 2008;15(10):1519-22. DOI: https://doi.org/10.1128/CVI.00109-08

Santino I, Longobardi V. Clinical and serological features of patients with suspected Lyme borreliosis. Int J Immunopathol Pharmacol. 2011;24(3):797-801. DOI: https://doi.org/10.1177/039463201102400327

Lipsker D, Antoni-Bach N, Hansmann Y, Jaulhac B. Long-term prognosis of patients treated for erythema migrans in France. Br J Dermatol. 2002;146(5):872-6. DOI: https://doi.org/10.1046/j.1365-2133.2002.04628.x